Christine Bellon - Nov 20, 2023 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Chief Legal Officer
Signature
By: /s/ Christine Bellon
Stock symbol
BEAM
Transactions as of
Nov 20, 2023
Transactions value $
-$232,800
Form type
4
Date filed
11/22/2023, 04:05 PM
Previous filing
Oct 4, 2023
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $30.2K +4.18K +5.08% $7.22 86.6K Nov 20, 2023 Direct F1
transaction BEAM Common Stock Options Exercise $42K +5.82K +6.72% $7.22 92.4K Nov 20, 2023 Direct F1
transaction BEAM Common Stock Sale -$150K -5K -5.41% $30.00 87.4K Nov 20, 2023 Direct F1
transaction BEAM Common Stock Sale -$155K -5K -5.72% $31.00 82.4K Nov 20, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -4.18K -30.58% $0.00 9.49K Nov 20, 2023 Common Stock 4.18K $7.22 Direct F2
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -5.82K -34.76% $0.00 10.9K Nov 20, 2023 Common Stock 5.82K $7.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.
F2 The option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.
F3 The option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested.